CTLA‐4 blockade with ipilimumab: biology, safety, efficacy, and future considerations

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|4|5|661-672

ISSN: 2045-7634

Source: Cancer Medicine, Vol.4, Iss.5, 2015-05, pp. : 661-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content